As one of the leading Biologics Discovery CROs in the world, ChemPartner provides a comprehensive service portfolio from conceptual biologics design to the pre-clinical (IND filing) stage. Our team of scientists has the full spectrum of specialty areas and extensive experience in biologics. Additionally, through our partnership with Berkeley Lights, Inc., ChemPartner can now offer accelerated monoclonal antibody (mAb) discovery workflow utilizing the Beacon® Optofluidic platform.
As more and more pharma and biotech companies look for alliance partners to provide intellectual contributions and exceptional technical expertise, ChemPartner is uniquely positioned to not only be a CRO, but to be a true pharmaceutical alliance partner. Our team of experienced scientists, western-trained pharmaceutical industry leaders, and experienced pharmaceutical executive leadership at the helm, ChemPartner is aligned and dedicated to technically and strategically accomplishing the research initiatives of pharma and biotech companies worldwide.